相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model
Xu-Qiao Chen et al.
ALZHEIMERS & DEMENTIA (2021)
Preclinical validation of a potent γ-secretase modulator for Alzheimer's disease prevention
Kevin D. Rynearson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders
Ana C. Silva et al.
BRAIN (2020)
Passive antiamyloid immunotherapy for Alzheimer's disease
Julia C. Loureiro et al.
CURRENT OPINION IN PSYCHIATRY (2020)
Down syndrome
Stylianos E. Antonarakis et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Modeling and Targeting Alzheimer's Disease With Organoids
Angelos Papaspyropoulos et al.
FRONTIERS IN PHARMACOLOGY (2020)
Further understanding the connection between Alzheimer's disease and Down syndrome
Heather M. Snyder et al.
ALZHEIMERS & DEMENTIA (2020)
A non-mosaic transchromosomic mouse model of down syndrome carrying the long arm of human chromosome 21
Yasuhiro Kazuki et al.
ELIFE (2020)
Rescuing Over-activated Microglia Restores Cognitive Performance in Juvenile Animals of the Dp(16) Mouse Model of Down Syndrome
Bruno Pinto et al.
NEURON (2020)
Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy
Yutong Zhou et al.
SCIENCE ADVANCES (2020)
Evolution of neuroinflammation across the lifespan of individuals with Down syndrome
Lisi Flores-Aguilar et al.
BRAIN (2020)
Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue
L. Lemoine et al.
MOLECULAR NEURODEGENERATION (2020)
Sex differences in risk of Alzheimer's disease in adults with Down syndrome
Florence Lai et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome
Alessandra C. Martini et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer's Disease
Anna Pensalfini et al.
CELL REPORTS (2020)
Alzheimer's disease drug development pipeline: 2020
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
Dementia in Down syndrome: unique insights for Alzheimer disease research
Ira T. Lott et al.
NATURE REVIEWS NEUROLOGY (2019)
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease
Carla M. Startin et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Single-cell transcriptomic analysis of Alzheimer's disease
Hansruedi Mathys et al.
NATURE (2019)
Cross talk between SOD1 and the mitochondrial UPR in cancer and neurodegeneration
Maria Gomez et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases
Ross W. Paterson et al.
NATURE REVIEWS NEUROLOGY (2019)
Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21
Maria Chiara Pelleri et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Neuropathological correlates of amyloid PET imaging in Down syndrome
Eric E. Abrahamson et al.
DEVELOPMENTAL NEUROBIOLOGY (2019)
Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species
Xu-Qiao Chen et al.
FRONTIERS IN NEUROSCIENCE (2019)
A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ (vol 104, pg 256, 2019)
Dylan Kwart et al.
NEURON (2019)
Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome
Amanda Sinai et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis
Katarzyna Marta Zoltowska et al.
MOLECULAR NEUROBIOLOGY (2018)
Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise
Christopher H. van Dyck
BIOLOGICAL PSYCHIATRY (2018)
Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome
Xu-Qiao Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease
Daniel J. Colacurcio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease
Joseph Park et al.
NATURE NEUROSCIENCE (2018)
Generation of human vascularized brain organoids
Missy T. Pham et al.
NEUROREPORT (2018)
Emerging Roles of Astrocytes in Neuro-Vascular Unit and the Tripartite Synapse With Emphasis on Reactive Gliosis in the Context of Alzheimer's Disease
Cai-Yun Liu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer's Disease
Yan Zhou et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome
Eleonore Bayen et al.
JAMA NEUROLOGY (2018)
The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome
Yvonne S. Davidson et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Non-human primates as a model for aging
Ricki J. Colman
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
Juan Fortea et al.
LANCET NEUROLOGY (2018)
The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease
Minghui Wang et al.
SCIENTIFIC DATA (2018)
Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer's Disease
Christy O. Y. Hung et al.
CELL REPORTS (2018)
Co-occurring medical conditions in adults with Down syndrome: A systematic review toward the development of health care guidelines
George T. Capone et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2018)
Estimation of the number of people with Down syndrome in the United States
Gert de Graaf et al.
GENETICS IN MEDICINE (2017)
Sex and the Development of Alzheimer's Disease
Christian J. Pike
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease
Ralph A. Nixon
FASEB JOURNAL (2017)
Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease
Sherry A. Ferguson et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP
Eric Doran et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome
Alexander M. Kleschevnikov et al.
NEUROBIOLOGY OF DISEASE (2017)
Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
Kathleen M. Schoch et al.
NEURON (2017)
Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models
Catherine Do et al.
EPIGENOMICS (2017)
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Elizabeth Head et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Intersectin scaffold proteins and their role in cell signaling and endocytosis
Erika Herrero-Garcia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology
Elizabeth Head et al.
CURRENT ALZHEIMER RESEARCH (2016)
Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease
S. Kim et al.
MOLECULAR PSYCHIATRY (2016)
Molecular genetics of early-onset Alzheimer's disease revisited
Rita Cacace et al.
ALZHEIMERS & DEMENTIA (2016)
The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration
Wei Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome
Joseph W. Goodliffe et al.
JOURNAL OF NEUROSCIENCE (2016)
Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model
Brian Spencer et al.
JOURNAL OF NEUROSCIENCE (2016)
Age, APOE and sex: Triad of risk of Alzheimer's disease
Brandalyn C. Riedel et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Mouse models of Down syndrome: gene content and consequences
Meenal Gupta et al.
MAMMALIAN GENOME (2016)
Clearance systems in the brain-implications for Alzheimer diseaser (vol 11, pg 457, 2015)
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2016)
Marmosets: A Neuroscientific Model of Human Social Behavior
Cory T. Miller et al.
NEURON (2016)
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination
Jose Luis Olmos-Serrano et al.
NEURON (2016)
An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome
Pavel V. Belichenko et al.
PLOS ONE (2016)
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
Arnaud Duchon et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2016)
Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases
Mariet Allen et al.
SCIENTIFIC DATA (2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome
Michael S. Rafii et al.
Frontiers in Behavioral Neuroscience (2015)
Targeting Prodromal Alzheimer Disease With Avagacestat A Randomized Clinical Trial
Vladimir Coric et al.
JAMA NEUROLOGY (2015)
Intraventricular Delivery of siRNA Nanoparticles to the Central Nervous System
Rishab Shyam et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes
Hoang S. Nhan et al.
ACTA NEUROPATHOLOGICA (2015)
Soluble γ-Secretase Modulators Selectively Inhibit the Production of the 42-Amino Acid Amyloid β Peptide Variant and Augment the Production of Multiple Carboxy-Truncated Amyloid β Species
Steven L. Wagner et al.
BIOCHEMISTRY (2014)
Estrogen: A master regulator of bioenergetic. systems in the brain and body
Jamaica R. Rettberg et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2014)
Central and Peripheral Administration of Antisense Oligonucleotide Targeting Amyloid-β Protein Precursor Improves Learning and Memory and Reduces Neuroinflammatory Cytokines in Tg2576 (AβPPswe) Mice
Susan A. Farr et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Overview and Findings from the Religious Orders Study
David A. Bennett et al.
Current Alzheimer Research (2013)
Atypical aging in down syndrome
Warren B. Zigman
Developmental Disabilities Research Reviews (2013)
Current Estimate of Down Syndrome Population Prevalence in the United States
Angela P. Presson et al.
JOURNAL OF PEDIATRICS (2013)
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
Liesi E. Hebert et al.
NEUROLOGY (2013)
BACE2 Expression Increases in Human Neurodegenerative Disease
Christopher J. Holler et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
Vladimir Coric et al.
ARCHIVES OF NEUROLOGY (2012)
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome
Giovanna Cenini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Peripheral Administration of Antisense Oligonucleotides Targeting the Amyloid-β Protein Precursor Reverses AβPP and LRP-1 Overexpression in the Aged SAMP8 Mouse Brain
Michelle A. Erickson et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells
Mason A. Israel et al.
NATURE (2012)
In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
Kristin R. Wildsmith et al.
PLOS ONE (2012)
Microglial pathology in Down syndrome
Qing-Shan Xue et al.
ACTA NEUROPATHOLOGICA (2011)
The cholinergic system in aging and neuronal degeneration
Reinhard Schliebs et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The role of DYRK1A in neurodegenerative diseases
Jerzy Wegiel et al.
FEBS JOURNAL (2011)
Plasma Amyloid-beta as a Function of Age, Level of Intellectual Disability, and Presence of Dementia in Down Syndrome
Elizabeth Head et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice
Tao Yu et al.
BRAIN RESEARCH (2010)
Microglia and Inflammation in Alzheimer's Disease
Shweta Mandrekar-Colucci et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions
Tao Yu et al.
HUMAN MOLECULAR GENETICS (2010)
Relationship Between Proteolytically Cleaved Gelsolin and Levels of Amyloid-beta Protein in the Brains of Down Syndrome Subjects
Lina Ji et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Estrogen Stimulates Degradation of β-Amyloid Peptide by Up-regulating Neprilysin
Kaiwei Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Down's Syndrome: Up-Regulation of β-Amyloid Protein Precursor and τ mRNAs and Their Defective Coordination
Fumitaka Oyama et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Alzheimer's-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition
Ying Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A γ-Secretase Inhibitor Decreases Amyloid-β Production in the Central Nervous System
Randall J. Bateman et al.
ANNALS OF NEUROLOGY (2009)
Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21
Robert Lyle et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease
Cassia R. Overk et al.
NEUROBIOLOGY OF DISEASE (2009)
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies
Jan O. Korbel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome
A. Salehi et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease
Adam S. Fleisher et al.
ARCHIVES OF NEUROLOGY (2008)
Functional consequences of locus coeruleus degeneration in Alzheimer's disease
David Weinshenker
CURRENT ALZHEIMER RESEARCH (2008)
Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome
Fei Liu et al.
FASEB JOURNAL (2008)
Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome
Jianhua Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein expression of BACE1, BACE2 and APP in down syndrome brains
M. S. Cheon et al.
AMINO ACIDS (2008)
Gene expression profiling in the adult Down syndrome brain
H. E. Lockstone et al.
GENOMICS (2007)
DYRK1A-mediated hyperphosphorylation of Tau - A functional link between Down syndrome and Alzheimer disease
Soo-Ryoon Ryoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain
A. Nistor et al.
NEUROBIOLOGY OF AGING (2007)
APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy
Kristel Sleegers et al.
BRAIN (2006)
Phenotype associated with APP duplication in five families
Lucie Cabrejo et al.
BRAIN (2006)
Dementia and mortality in persons with Down's syndrome
A. Coppus et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2006)
Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration
Ahmad Salehi et al.
NEURON (2006)
Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease
A von Gunten et al.
NEUROBIOLOGY OF AGING (2006)
Gene structure and organization of the human β-secretase (BACE) promoter
K Sambamurti et al.
FASEB JOURNAL (2004)
Aβ localization in abnormal endosomes:: association with earliest Aβ elevations in AD and Down syndrome
AM Cataldo et al.
NEUROBIOLOGY OF AGING (2004)
Onset of dementia is associated with age at menopause in women with Down's syndrome
N Schupf et al.
ANNALS OF NEUROLOGY (2003)
Characteristic developmental expression of amyloid β40, 42 and 43 in patients with Down syndrome
A Hirayama et al.
BRAIN & DEVELOPMENT (2003)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Intraneuronal Aβ42 accumulation in Down syndrome brain
C Mori et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2002)
Differential gene expression studies to explore the molecular pathophysiology of Down syndrome
SE Antonarakis et al.
BRAIN RESEARCH REVIEWS (2001)
Elevated plasma amyloid β-peptide 1-42 and onset of dementia in adults with Down syndrome
N Schupf et al.
NEUROSCIENCE LETTERS (2001)
To ERR (meiotically) is human: The genesis of human aneuploidy
T Hassold et al.
NATURE REVIEWS GENETICS (2001)
Nerve growth factor signaling, neuroprotection, and neural repair
MV Sofroniew et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer's disease and Down syndrome -: Differential effects of APOE genotype and presenilin mutations
AM Cataldo et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice:: Synaptotoxicity without plaque formation
L Mucke et al.
JOURNAL OF NEUROSCIENCE (2000)
Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation
S Kumar-Singh et al.
NEUROBIOLOGY OF DISEASE (2000)
分享论文
